Additional effects of pioglitazone on type 2 diabetes who were inappropriately controlled with insulin therapy.

Trial Profile

Additional effects of pioglitazone on type 2 diabetes who were inappropriately controlled with insulin therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2011

At a glance

  • Drugs Antihyperglycaemics; Pioglitazone
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms ACTION-J
  • Most Recent Events

    • 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 26 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top